Mark Foley | executive |
Tobin Schilke | executive |
Seamus Fernandez | analyst |
Chris Shibutani | analyst |
Stacy Ku | analyst |
Mikaela Franceschina | analyst |
David Amsellem | analyst |
Annabel Samimy | analyst |
Lachlan Hanbury-Brown | analyst |
Uy Ear | analyst |
Serge Belanger | analyst |
Navann Ty Dietschi | analyst |
Welcome to the Revance Therapeutics Second Quarter 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, August 8, 2024. I will now hand the call over to your host, Laurence Watts, Revance Therapeutics.